| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HARROW, INC. | CEO & President, ImprimisRx | Common Stock | 467,388 | $10,791,989 | $23.09 | 07 Apr 2025 | Direct |
| HARROW, INC. | CEO & President, ImprimisRx | Performance Stock Unit | 0 | $0 | $23.09 | 03 Apr 2025 | Direct |
| HARROW, INC. | CEO & President, ImprimisRx | Stock Option (Right to Buy) | 0 | 11 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HROW | HARROW, INC. | 03 Apr 2025 | 3 | -$2,527,778 | 4 | CEO & President, ImprimisRx | 07 Apr 2025, 21:54 |
| HROW | HARROW, INC. | 11 Sep 2024 | 3 | -$1,204,142 | 4 | CEO of ImprimisRx | 13 Sep 2024, 17:26 |
| HROW | HARROW, INC. | 01 Mar 2024 | 2 | +$43,750 | 4 | CEO of ImprimisRx | 06 Mar 2024, 06:06 |
| HROW | HARROW, INC. | 20 Feb 2024 | 3 | +$185,487 | 4 | CEO of ImprimisRx | 21 Feb 2024, 19:30 |
| HROW | HARROW, INC. | 10 Nov 2023 | 3 | -$125,452 | 4 | Chief Commercial Officer | 14 Nov 2023, 19:02 |
| HROW | HARROW HEALTH, INC. | 18 Jul 2023 | 3 | -$1,988,528 | 4 | Chief Commercial Officer | 20 Jul 2023, 19:46 |
| HROW | HARROW HEALTH, INC. | 03 Apr 2023 | 1 | $0 | 4 | Chief Commercial Officer | 04 Apr 2023, 19:52 |
| HROW | HARROW HEALTH, INC. | 19 Feb 2022 | 3 | -$204,014 | 4 | President, ImprimisRx | 23 Feb 2022, 17:00 |
| HROW | HARROW HEALTH, INC. | 23 Jul 2021 | 1 | $0 | 4 | President, ImprimisRx | 23 Jul 2021, 17:40 |